Looking at the
Evidence for New Drugs
Recent
headlines about Vytorin, a drug prescribed
to millions of patients to help lower
cholesterol levels, raise questions about
FDA drug approvals and benefits to patients.
After years on the market, studies revealed
Vytorin does not prevent heart attacks or
strokes, as it was intended to do.
The
Vytorin results follow on the heels of other
drugs that had been prescribed for patients,
were later found to be harmful, and were
pulled off the market. The abrupt
withdrawals of Vioxx, Rezulin, Baycol and
others left doctors and patients reeling.
Why
were these drugs approved by the Food and
Drug Administration (FDA) to begin with if
they didn’t work, or were dangerous?
Unfortunately, the FDA may approve a drug
without knowing that problems exist. Its own
approval process for reviewing new drugs
does not require manufacturers to reveal
everything they know. Recent cases have
shown that negative drug study results have
sometimes been withheld by manufacturers
seeking approval for new drugs.
Knowing it’s possible a drug can be
prescribed that may harm us, or simply won’t
be helpful, means we need to be that much
more cautious when we are given a new
prescription.
To
be clear, I’m not talking about a drug’s
known side effects or contra-indications.
Your doctor should be aware of those, and
they will be documented in the drug’s
literature. But there may be problems your
doctor is not aware of because the
manufacturer has not made them available to
professionals or the public.
If
your doctor prescribes a drug that’s new to
you, ask her how long it has been available.
If the drug is generic, or has a generic
version, then it will already have a
well-documented track record.
If
the drug is too new to have a generic
version, then make sure it has at least a
two or three year history to draw from. You
can do an Internet search to see if anyone
has raised questions about its safety or
effectiveness.
If
the drug is newer than two or three years,
then ask your doctor to help you weigh the
pros and cons, knowing that it’s possible
neither of you will know about possible
negative outcomes.
Does all this sound a bit paranoid? Perhaps.
But knowing the FDA isn’t holding
manufacturers accountable means we patients
need to be smarter to stay safe.
Return to Main List
of Columns
TOP
Trisha Torrey is Every Patient’s
AdvocateTM.
She offers no medical advice,
but empowers those who
want to learn more about
diagnosis and treatment options
by
providing useful tools and
resources.
|